According to the current analysis of Reports and Data, the global Nucleic Acid Amplification Testing (NAAT) market was valued at USD 2.315 Billion in 2018 and is expected to reach USD 4.549 Billion by year 2026, at a CAGR of 8.8 %. The study covers Nucleic acid which a complex organic substance essential to all forms of life. It is present in living cells as RNA and DNA, composed of nucleotides linked in a long chain. Whereas, Nucleic acid amplification testing is a method of testing the blood to detect pathogen causing bacteria or virus in in blood, tissue, urine, etc.
The nucleic acid amplification testing is widely used in the field of diagnostics. With market players exploring the applications of nucleic acid amplification testing, and it is expected to be adopted in new disease fields for the diagnostics and monitoring purpose. For instance, Gen-Probe, Inc., a US based Clinical Diagnostics company, introduced three assays based on its transcription-mediated amplification technology: the APTIMA CT assay (ACT), which detects C. trachomatis, the APTIMA GC assay (AGC), which detects Neisseria gonorrhoeae, and the APTIMA COMBO 2 assay (AC2), which detects both pathogens.
Increasing need for advanced diagnostic methods, wide range of applications in identification and monitoring of numerous diseases, increasing investment in the diagnostics sector, initiatives by governments all over the globe, extensive range of uses, growing demand from blood banks and transfusion centers, technological development in healthcare sector, are some of the prominent factors propelling nucleic acid amplification testing market growth in the industry.
However, associated safety concerns related to the nucleic acid amplification testing process, and dearth of sophisticated infrastructure essential for these kind of advanced technology in some developing nations, are the major hindrances restraining the nucleic acid amplification testing market growth during 2019-2026.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Key Players covered in this report are
Siemens Healthcare GmbH, Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd, Grifols SA, Becton, Illumina Inc., Dickinson and Company, Beckman Coulter Inc., Bio-Rad Laboratories, and bioMrieux SA
Technique Type (Revenue, USD Million; 2016–2026)
- Target Amplification
- Probe Amplification
- Signal Amplification
Application Type (Revenue, USD Million; 2016–2026)
- Infectious Diseases
- Cancer
- Personalized Medicine
- Genetic
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East Africa
Request a sample Report of Nucleic Acid Amplification Testing (NAAT) Market @ https://www.reportsanddata.com/request-customization-form/2187
Major Points covered in this report are as below:
• The Nucleic Acid Amplification Testing (NAAT) industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
• The Nucleic Acid Amplification Testing (NAAT) Market report provides key statistics on the market status of the Nucleic Acid Amplification Testing (NAAT) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
